Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Praxis Genomics is a CAP-accredited and CLIA-certified diagnostic laboratory based in Atlanta, Georgia, that specializes in high-resolution genetic testing and clinical consultation. The company is a pioneer in integrating multiple advanced genomic technologies, including whole genome sequencing (WGS), optical genome mapping (OGM), and whole transcriptome sequencing (RNA-seq), into a single clinical workflow. This multi-omics approach is designed to overcome the limitations of traditional genetic testing methods, such as microarrays and exome sequencing, by detecting complex structural variants and rearrangements. Praxis Genomics primarily serves patients with undiagnosed rare diseases, constitutional disorders, and cancer, as well as providing prenatal and carrier screening services. By leveraging state-of-the-art platforms from Bionano Genomics, Illumina, and Oxford Nanopore, the company aims to maximize diagnostic yields and provide actionable insights for personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Praxis Genomics.